VCYT
VCYT
NASDAQ · Biotechnology

Veracyte Inc

$40.42
-0.34 (-0.83%)
As of May 9, 9:35 PM ET ·
Financial Highlights (FY 2026)
Revenue
499.46M
Net Income
64.08M
Gross Margin
70.1%
Profit Margin
12.8%
Rev Growth
+20.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 499.46M 414.94M 507.99M 466.85M
Gross Profit 350.12M 290.87M 340.77M 313.18M
Operating Income 55.79M 41.71M -2,427,180 -2,364,906
Net Income 64.08M 47.91M -2,027,984 -2,410,114
Gross Margin 70.1% 70.1% 67.1% 67.1%
Operating Margin 11.2% 10.1% -0.5% -0.5%
Profit Margin 12.8% 12.2% -0.4% -0.5%
Rev Growth +20.4% +20.4% +16.6% +7.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 875.10M 761.72M
Total Equity 1.67B 1.94B
D/E Ratio 0.52 0.39
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 57.38M 45.29M -2,983,128 -2,794,572
Free Cash Flow -1,866,923 -2,624,091